Licensing Opportunity: Texas A&M Research Advances Nanotechnology for Potential Parkinson’s Disease Treatment
By: Crystal Carter
Texas A&M University researchers have developed a promising nanotechnology that could lead to new treatments for neurodegenerative diseases and traumatic brain injuries. Millions of people worldwide are affected by neurological conditions such as Alzheimer’s disease, Parkinson’s disease, stroke, and traumatic brain injury. A major challenge in treating these conditions is mitochondrial dysfunction, which contributes to oxidative stress and damage to nerve cells.
Led by Dr. Dmitry Kurouski, associate professor in the Department of Biochemistry and Biophysics at Texas A&M University, researchers have developed molybdenum diselenide nanoflowers, tiny flower-shaped structures designed to improve mitochondrial health and protect neurological cells from damage. Early laboratory studies have demonstrated promising results, including reductions in harmful reactive oxygen species by up to 80%, improvements in mitochondrial function by up to 99%, and increased cell proliferation by up to 35%. Studies involving nematodes also showed lifespan extensions of up to 33%.
Produced through a simple, cost-effective synthesis process, this patent-pending technology offers a promising approach to developing neuroprotective therapeutics.
Market Applications
The technology presents several opportunities for development across the healthcare and biotechnology industries:
- Neurodegenerative Disease Therapies: Potential treatments for Alzheimer’s disease, Parkinson’s disease, and other neurological disorders associated with mitochondrial dysfunction.
- Neurotraumatic Injury Treatments: Development of therapies targeting cellular damage associated with stroke, traumatic brain injury, and spinal cord injuries.
- Biomedical Research: Research tools for investigating mitochondrial function, oxidative stress, and neuroprotection in neurological diseases.
- Longevity and Healthy Aging: Potential development of healthspan-enhancing supplements and therapies, supported by preliminary findings demonstrating extended lifespan in nematodes.
Licensing Opportunities
Texas A&M Innovation is seeking industry partners interested in licensing, joint development, manufacturing partnerships, or strategic investment to advance this promising technology toward commercialization. Contact Stewart Davis, Assistant Director, Licensing at sdavis@tamus.edu for more information.

